MSOS:NYE-AdvisorShares Pure US Cannabis ETF (USD)

ETF | Others |

Last Closing

USD 6.81

Change

-0.09 (-1.30)%

Market Cap

USD 0.87B

Volume

7.19M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

The fund is an actively managed ETF that seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that derive at least 50% of their net revenue from the marijuana and hemp business in the United States and in derivatives that have economic characteristics similar to such securities. It will concentrate at least 25% of its investments in the pharmaceuticals, biotechnology & life sciences industry group within the health care sector. The fund is non-diversified.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-18 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
SOJE Southern Company (The) Series ..

-0.05 (-0.23%)

USD 65.72B
JEPI JPMorgan Equity Premium Income..

-0.16 (-0.27%)

USD 35.41B
DFAC Dimensional U.S. Core Equity 2..

-0.08 (-0.24%)

USD 29.38B
DTB DTE Energy Company 2020 Series

+0.31 (+1.46%)

USD 26.58B
SGOV iShares® 0-3 Month Treasury B..

+0.03 (+0.03%)

USD 25.69B
JPST JPMorgan Ultra-Short Income ET..

-0.03 (-0.06%)

USD 25.59B
GBTC Grayscale Bitcoin Trust (BTC)

+0.02 (+0.04%)

USD 23.75B
AVUV Avantis® U.S. Small Cap Value..

-0.02 (-0.02%)

USD 13.04B
JAAA Janus Detroit Street Trust - J..

+0.01 (+0.02%)

USD 12.23B
DFUV Dimensional US Marketwide Valu..

-0.03 (-0.07%)

USD 10.93B

ETFs Containing MSOS

YOLO AdvisorShares Pure Cannab.. 45.14 % 0.00 %

-0.01 (0%)

USD 0.04B
BUDX 23.56 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -2.85% 10% F 21% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -2.85% 7% C- 19% F
Trailing 12 Months  
Capital Gain -17.15% 5% F 11% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -17.15% 4% F 11% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -20.91% 2% F 3% F
Dividend Return -20.91% 1% F 3% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 41.44% 5% F 23% F
Risk Adjusted Return -50.46% 10% F 6% D-
Market Capitalization 0.87B 88% B+ 55% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.